NCT00827099 · OUTCOME

Number of Patients That Engrafted Blood Counts by 30 Days After Transplant

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer · Source last updated 2012-03-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: Day 30

What was measured

Number of patients whose Absolute Neutrophil Count (ANC) recovered to \>500 x10\^3/uL for at least 3 consecutive days after transplant

Groups in this outcome

Umbilical Cord Blood Transplant

High dose conditioning with Fludarabine \& Melphalan

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Umbilical Cord Blood Transplant	5

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Umbilical Cord Blood Transplant	5	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
5

denoms

counts
group Id
OG000
value
5
units
Participants

description

Number of patients whose Absolute Neutrophil Count (ANC) recovered to \>500 x10\^3/uL for at least 3 consecutive days after transplant

groups

description
High dose conditioning with Fludarabine \& Melphalan
id
OG000
title
Umbilical Cord Blood Transplant

param Type

NUMBER

reporting Status

POSTED

time Frame

Day 30

title

Number of Patients That Engrafted Blood Counts by 30 Days After Transplant

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice